cFLIP inhibition or down-regulation has therefore been proposed as a potential cancer therapy with the assumption that this will operate by sensitizing tumor cells to Fas-, TRAIL-, or TNF-induced cell death (for a review, see Ref. Here, TNFSF10 is linked to cancer.